Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal fluid retention in the gut lumen is a physiological state characterized by the accumulation of water and electrolytes within the intestinal cavity. It is not a discrete molecular target, such as a receptor or enzyme, but rather a complex biological process regulated by the coordinated activity of various ion transporters and channels, including the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), Sodium-Hydrogen Exchanger 3 (NHE3), and Guanylate Cyclase-C (GC-C) (Barrett, K. E., Gastrointestinal Physiology, 2014). In clinical practice, inducing fluid retention is a therapeutic goal for treating conditions like chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C), as increased luminal volume softens stool and promotes peristalsis (Lacy et al., Therapeutic Advances in Gastroenterology, 2008). Conversely, pathological fluid retention is the primary mechanism of secretory diarrhea, often triggered by bacterial toxins that overactivate secretory pathways (Lembo et al., American Journal of Gastroenterology, 2011). Pharmacological agents such as linaclotide, plecanatide, and tenapanor target specific proteins to modulate this fluid balance for therapeutic effect (Spencer et al., Drugs, 2014).
Inducing fluid retention via activation of chloride channels (e.g., CFTR, ClC-2), inhibition of sodium absorption (e.g., NHE3), or osmotic draw of water into the lumen.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal fluid retention in the gut lumen.